Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950)
1,996.00
-14.00 (-0.70%)
At close: Oct 2, 2026
Kyung Nam Pharm Market Cap
Kyung Nam Pharm has a market cap or net worth of 39.16 billion as of October 2, 2026. Its market cap has decreased by -15.07% in one year.
Market Cap
39.16B
Enterprise Value
39.93B
Revenue
54.89B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,996.00
ChartMarket Cap Chart
Since March 1, 2002, Kyung Nam Pharm's market cap has increased from 11.99B to 39.16B, an increase of 226.61%. That is a compound annual growth rate of 4.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 39.16B | -26.09% |
| Dec 30, 2025 | 52.98B | -15.36% |
| Dec 30, 2024 | 62.60B | 4.56% |
| Dec 28, 2023 | 59.87B | -27.59% |
| Dec 29, 2022 | 82.68B | -6.60% |
| Dec 30, 2021 | 88.52B | -37.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BL Pharmtech | 60.98B |
| Hwail Pharmaceutical | 54.10B |
| RP Bio | 51.48B |
| Jin Yang Pharmaceutical | 50.93B |
| Organoidsciences | 45.51B |
| GeneBioTech Co. ,Ltd | 42.54B |
| Eagle Veterinary Technology Co.,Ltd | 39.06B |
| Korean Drug | 35.41B |